Ion Beam Applications SA IBA (GB:0GZK) has released an update.
Ion Beam Applications (IBA), a global leader in proton therapy solutions for cancer treatment, has issued a transparency notification after Vallcara Limited’s acquisition of voting rights surpassed the 3% threshold on September 24, 2024. The disclosure follows regulations set by the Transparency Law regarding major shareholdings. Vallcara Limited, now a significant shareholder, manages its voting rights independently and is part of a controlled undertaking with Vallgesa Limited in Malta.
For further insights into GB:0GZK stock, check out TipRanks’ Stock Analysis page.
